newsfilter
← Latest News
ACCESS Newswire·

Lexaria Comments on Study Examining Cannabinoids and SARS-CoV-2

"Cannabinoids have the potential to prevent as well as treat infection by SARS-CoV-2" KELOWNA, BC / ACCESSWIRE / January 18, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery pl